Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,802.00
(
-1.37%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.54
(
6.84%
)
Bitcoin
70,759.07
(
-4.31%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: elmono post# 54017

Tuesday, 10/30/2007 2:07:57 PM

Tuesday, October 30, 2007 2:07:57 PM

Post# of 257253
>Pharming already received an orphan designation [for HAE] more than a year ago.<

I do not understand your point. Orphan-drug marketing exclusivity goes to the first drug to be approved, not the first drug to receive an orphan designation.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now